Hypercholesterolemia
📧 Sign up to get email alerts when something new happens for Hypercholesterolemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-02-10Clinical Trial Update: Open-Label Extension to Evaluate the Longer Term Efficacy and Safety of LIB003 [Phase 2]
Phase 2 open-label extension evaluating longer-term efficacy and safety of LIB003 in hypercholesterolemia.
-
CLINICAL_TRIALS trial_result · 2022-01-25Clinical Trial Update: Study to Evaluate the Efficacy and Safety in Patients With Primary Hypercholesterolemia [Phase 3]
Phase 3 trial evaluating efficacy and safety for primary hypercholesterolemia; status is unknown.
-
CLINICAL_TRIALS trial_result · 2022-01-14Clinical Trial Update: Evaluating the Efficacy of Pediatric Lipid Screening Alerts [NA]
A completed pediatric trial evaluating lipid screening alerts to improve identification or management of high cholesterol in children; resul…
-
CLINICAL_TRIALS research · 2022-01-13Clinical Trial Update: Evaluation of the Effect of a Shiitake Extract on Lipid Profile in Subjects With Moderate Hyperlipidemia [Phase 4]
A Phase 4 clinical trial evaluating the effect of a shiitake extract on lipid profiles in adults with moderate hyperlipidemia has been compl…
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: Pharmacy Home Adherence Reporting and Monitoring Outcomes Study [NA]
A completed clinical trial examining pharmacy home adherence reporting and monitoring outcomes for patients with diabetes and hypertension (…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-12-01Clinical Trial Update: To Evaluate the Efficacy and Safety in Patients With Primary Hypercholesterolemia [Phase 3]
Phase 3 clinical trial evaluating efficacy and safety in patients with primary hypercholesterolemia has completed.
-
FDA approval · 2021-10-19FDA Approved: CHOLEYSTYRAMINE LIGHT — Original Application (Ascend Laboratories, LLC)
FDA approved CHOLEYSTYRAMINE LIGHT from Ascend Laboratories, LLC as an original ANDA product.
-
FDA approval · 2021-09-14FDA Approved: CHOLESTYRAMINE — Supplemental Application (Ajanta Pharma USA Inc.)
The FDA approved a supplemental application for cholestyramine filed by Ajanta Pharma USA Inc., indicating an update to the product's approv…
-
CLINICAL_TRIALS trial_result · 2021-08-20Clinical Trial Update: Safety and Efficacy of Evolocumab in Addition to Optimal Stable Background Statin Therapy in Chinese Participants With Primary Hypercholesterolemia and Mixed Dyslipidemia [Phase 3]
Phase 3 trial in Chinese participants evaluating evolocumab added to background statin therapy for primary hypercholesterolemia and mixed dy…
-
CLINICAL_TRIALS trial_result · 2021-08-13Clinical Trial Update: Effects of Atorvastatin in Graves' Orbitopathy (GO) [Phase 2]
Phase 2 trial update evaluating the effects of atorvastatin in Graves' orbitopathy (thyroid-associated ophthalmopathy) and hypercholesterole…
-
FDA approval · 2021-07-14FDA Approved: ATORVASTATIN CALCIUM — Original Application (Dr. Reddy's Laboratories Inc)
The FDA approved Dr. Reddy's Laboratories' atorvastatin calcium as a generic tablet under an Original Application (ANDA214659), authorizing …
-
FDA approval · 2021-06-03FDA Approved: FENOFIBRATE — Supplemental Application (NorthStar RxLLC)
The FDA approved a supplemental application for fenofibrate submitted by NorthStar RxLLC.
-
CLINICAL_TRIALS trial_result · 2021-05-20Clinical Trial Update: Effect of Atorvastatin on Bone-vascular Axis [Phase 4]
Phase 4 trial evaluating the effect of atorvastatin on bone-vascular axis in osteoporosis and hypercholesterolemia; completed with results p…
-
CLINICAL_TRIALS trial_result · 2021-05-12Clinical Trial Update: Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan/Amlodipine [Phase 3]
Phase 3 trial assessing the efficacy and safety of co-administered Rosuvastatin/Ezetimibe with Telmisartan/Amlodipine for hypercholesterolem…
-
CLINICAL_TRIALS trial_result · 2021-05-07Clinical Trial Update: Evaluating Effect of the Study Drug Praluent (Alirocumab) on Neurocognitive Function When Compared to Placebo [Phase 4]
Phase 4 clinical trial evaluating the neurocognitive effects of alirocumab (Praluent) versus placebo in hypercholesterolemia.
-
FDA approval · 2021-05-04FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA granted supplemental approval for atorvastatin calcium from Dr. Reddy's Laboratories Limited under an ANDA.
-
FDA approval · 2021-03-15FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for pravastatin sodium to allow Aurobindo Pharma Limited to market a generic pravastatin product in …
-
FDA approval · 2021-03-09FDA Approved: CHOLESTYRAMINE — Original Application (Precision Dose, Inc.)
FDA approved an original ANDA for cholestyramine from Precision Dose, Inc., providing a generic version of the bile acid sequestrant.
-
FDA approval · 2021-03-05FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for Accord Healthcare's generic pravastatin sodium, updating its regulatory status as an approved ge…
-
CLINICAL_TRIALS trial_result · 2021-03-05Clinical Trial Update: Efficacy and Safety of HGP1910 and HCP1903 in Patients With Primary Hypercholesterolemia [Phase 3]
Phase 3 trial update assessing efficacy and safety of HGP1910 and HCP1903 in patients with primary hypercholesterolemia.
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: Canadians Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration [Phase 3]
Phase 3 trial updating on atorvastatin stratified titration to achieve cholesterol targets in Canadians with hypercholesterolemia.
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: Efficacy And Safety Study Of Atorvastatin Versus Simvastatin In Type 2 Diabetic Subjects With Hypercholesterolemia [Phase 4]
Phase 4 trial comparing atorvastatin to simvastatin in type 2 diabetes patients with hypercholesterolemia has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: Comparative Atorvastatin Pleiotropic Effects [Phase 4]
Phase 4 clinical trial update evaluating pleiotropic effects of atorvastatin in coronary arteriosclerosis and hypercholesterolemia, complete…
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: A Study To Evaluate The Safety And Efficacy Of Atorvastatin In Patients With Diabetes And High Cholesterol [Phase 4]
Phase 4 trial update evaluating safety and efficacy of atorvastatin in patients with diabetes and high cholesterol has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Effectiveness of Treatment of Hypercholesterolemia With Rosuvastatin and Ezetimibe [Phase 4]
A phase 4 trial update assessing the effectiveness of rosuvastatin plus ezetimibe for hypercholesterolemia has been completed.